Search Results - "proteomics"
Suggested Topics within your search.
Suggested Topics within your search.
- Proteomics 17
- analysis
- methods 17
- Methodology 14
- Proteome 14
- Biochemical markers 12
- Biomarkers 12
- Diseases 9
- Cardiovascular Diseases 8
- Cardiovascular system 6
- Kidney Diseases 6
- Kidneys 6
- Analysis 5
- Proteins 5
- diagnosis 5
- Molecular Diagnostic Techniques 3
- Molecular diagnosis 3
- physiopathology 3
- Cancer 2
- Cell organelles 2
- Chloroplasts 2
- Complex Mixtures 2
- DNA 2
- Diagnosis 2
- Heart Disease Risk Factors 2
- Isotope Labeling 2
- Lung Neoplasms 2
- Mass Spectrometry 2
- Mass spectrometry 2
- Mesothelioma 2
-
1
The proteomic revolution
Published 2012Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
2
The proteomic revolution
Published 2022Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
3
The chloroplast proteome
Published 2021Table of Contents: “…Contents: What is proteomics and what does it measure? -- Protein identification by mass spectrometry -- The problem of complex mixtures and protein identification -- Quantitative proteomics and stable isotope labeling -- Intact protein mass measurements and top-down proteomics.…”
Get full text
Series
Electronic Video -
4
The chloroplast proteome
Published 2021Table of Contents: “…Contents: What is proteomics and what does it measure? -- Protein identification by mass spectrometry -- The problem of complex mixtures and protein identification -- Quantitative proteomics and stable isotope labeling -- Intact protein mass measurements and top-down proteomics.…”
Get full text
Series
Electronic Video -
5
The proteomic revolution
Published 2022Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
6
Proteomic technologies and targets an overview /
Published 2013Table of Contents: “…Contents: Introduction -- The relationship between genome and proteome -- Why should we analyse the proteome? -- Challenges in proteome analysis -- Dynamic range of the proteome -- Complexity of the proteome -- Spatiotemporal organisation -- Dynamic changes in protein concentrations and modifications -- Technologies for analysing the proteome -- Mass spectrometry -- Protein arrays -- Imaging -- Data analysis -- The applications of clinical proteomics -- Biomarkers -- Systems biology approaches.…”
Get full text
Series
Electronic Video -
7
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
8
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
9
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
10
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
11
Proteomic technologies and targets an overview /
Published 2013Table of Contents: “…Contents: Introduction -- The relationship between genome and proteome -- Why should we analyse the proteome? -- Challenges in proteome analysis -- Dynamic range of the proteome -- Complexity of the proteome -- Spatiotemporal organisation -- Dynamic changes in protein concentrations and modifications -- Technologies for analysing the proteome -- Mass spectrometry -- Protein arrays -- Imaging -- Data analysis -- The applications of clinical proteomics -- Biomarkers -- Systems biology approaches.…”
Get full text
Series
Electronic Video -
12
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
13
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
14
Proteomic technologies and targets an overview /
Published 2013Table of Contents: “…Contents: Introduction -- The relationship between genome and proteome -- Why should we analyse the proteome? -- Challenges in proteome analysis -- Dynamic range of the proteome -- Complexity of the proteome -- Spatiotemporal organisation -- Dynamic changes in protein concentrations and modifications -- Technologies for analysing the proteome -- Mass spectrometry -- Protein arrays -- Imaging -- Data analysis -- The applications of clinical proteomics -- Biomarkers -- Systems biology approaches.…”
Get full text
Series
Electronic Video -
15
Urinary proteomics in kidney and cardiovascular disease
Published 2013Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
16
Urinary proteomics in kidney and cardiovascular disease
Published 2013Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
17
Urinary proteomics in kidney and cardiovascular disease
Published 2013Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video